SEC Form 4 · accession 0001645627-17-000029
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
Apr 5, 2017
Accepted (ET)
Apr 10, 2017 · 10:32 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 5, 2017 | P | 1,000 | $0.096 | A | 20,059,849 | D | |
| Common Stock | Apr 5, 2017 | P | 1,000 | $0.0899 | A | 20,060,849 | D | |
| Common Stock | Apr 5, 2017 | P | 20,060,849 | $0.0929 | A | 20,061,849 | D | |
| Common Stock | Apr 5, 2017 | P | 1,000 | $0.0925 | A | 20,062,849 | D | |
| Common Stock | Apr 5, 2017 | P | 1,000 | $0.089 | A | 20,063,849 | D | |
| Common Stock | Apr 5, 2017 | P | 1,000 | $0.0924 | A | 20,064,849 | D | |
| Common Stock | Apr 5, 2017 | P | 1,000 | $0.0923 | A | 20,065,849 | D | |
| Common Stock | Apr 5, 2017 | P | 1,000 | $0.0912 | A | 20,066,849 | D | |
| Common Stock | Apr 6, 2017 | P | 1,000 | $0.0737 | A | 20,067,849 | D | |
| Common Stock | Apr 6, 2017 | P | 1,000 | $0.074 | A | 20,068,849 | D | |
| Common Stock | Apr 6, 2017 | P | 1,000 | $0.077 | A | 20,069,849 | D | |
| Common Stock | Apr 6, 2017 | P | 1,000 | $0.078 | A | 20,070,849 | D | |
| Common Stock | Apr 6, 2017 | P | 1,000 | $0.079 | A | 20,071,849 | D | |
| Common Stock | Apr 6, 2017 | P | 1,000 | $0.0808 | A | 20,072,849 | D | |
| Common Stock | Apr 6, 2017 | P | 1,000 | $0.08 | A | 20,073,849 | D | |
| Common Stock | Apr 6, 2017 | P | 1,000 | $0.077 | A | 20,074,849 | D | |
| Common Stock | Apr 6, 2017 | P | 1,000 | $0.077 | A | 20,075,849 | D | |
| Common Stock | Apr 6, 2017 | P | 1,000 | $0.0799 | A | 20,076,849 | D | |
| Common Stock | Apr 6, 2017 | P | 1,000 | $0.081 | A | 20,077,849 | D | |
| Common Stock | Apr 6, 2017 | P | 1,000 | $0.0849 | A | 20,078,849 | D | |
| Common Stock | Apr 6, 2017 | P | 1,000 | $0.0848 | A | 20,079,849 | D | |
| Common Stock | Apr 7, 2017 | P | 1,000 | $0.086 | A | 20,080,849 | D | |
| Common Stock | Apr 7, 2017 | P | 1,000 | $0.087 | A | 20,081,849 | D | |
| Common Stock | Apr 7, 2017 | P | 1,000 | $0.087 | A | 20,082,849 | D | |
| Common Stock | Apr 7, 2017 | P | 1,000 | $0.087 | A | 20,083,849 | D | |
| Common Stock | Apr 7, 2017 | P | 1,000 | $0.0881 | A | 20,084,849 | D | |
| Common Stock | Apr 7, 2017 | P | 1,000 | $0.089 | A | 20,085,849 | D | |
| Common Stock | Apr 7, 2017 | P | 1,000 | $0.089 | A | 20,086,849 | D | |
| Common Stock | Apr 7, 2017 | P | 1,000 | $0.0881 | A | 20,087,849 | D | |
| Common Stock | Apr 7, 2017 | P | 1,000 | $0.089 | A | 20,088,849 | D |
Table II — derivative securities
No Table II lines on this filing.